1 Exercise, PTGS2 expression, and colorectal cancer survival Cancer Epidemiology, Biomarkers & Prevention, May 23, 2013
2 Randomised clinical trial: evaluation of the efficacy of mesalazine (mesalamine) suppositories in patients with ulcerative colitis and active rectal inflammation – a placebo-controlled study Alimentary Pharmacology and Therapeutics, June 6, 2013
3 Gender affects acute organ toxicity during radiochemotherapy for rectal cancer: Long-term results of the German CAO/ARO/AIO-94 phase III trial Radiotherapy & Oncology, June 14, 2013
4 The impact of prostate volume, number of biopsy cores and American urological association symptom score on the sensitivity of cancer detection using the prostate cancer prevention trial risk calculator The Journal of Urology, June 13, 2013
5 Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based study Diabetic Medicine, June 13, 2013 Review Article
6 Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial BJU International, June 11, 2013
7 Effect of selective alpha-blocker tamsulosin on erectile function in patients with lower urinary tract symptoms due to benign prostatic hyperplasia Urology, May 30, 2013
8 Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer Radiotherapy & Oncology, May 29, 2013 Review Article
9 Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle cores Urology, June 3, 2013
10 Outcomes after recto-anastomosis fistula repair in patients who underwent radical prostatectomy for prostate cancer BJU International, June 6, 2013
Sponsor
Register now to view all the MDLinx contents (FREE)!
Login
Sponsor
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close
Sponsor